Scientific rationale and study design of the individualized dosing efficacy vs flat dosing to assess optimal pegylated interferon therapy (IDEAL) trial: determining optimal dosing in patients with genotype 1 chronic hepatitis C. (Q42977367)
Jump to navigation
Jump to search
scientific article published on 24 March 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Scientific rationale and study design of the individualized dosing efficacy vs flat dosing to assess optimal pegylated interferon therapy (IDEAL) trial: determining optimal dosing in patients with genotype 1 chronic hepatitis C. |
scientific article published on 24 March 2008 |
Statements
1 reference
Scientific rationale and study design of the individualized dosing efficacy vs flat dosing to assess optimal pegylated interferon therapy (IDEAL) trial: determining optimal dosing in patients with genotype 1 chronic hepatitis C. (English)
1 reference
M Sulkowski
1 reference
J McHutchison
1 reference
24 March 2008
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference